- Report
- May 2025
- 198 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- October 2018
- 134 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- July 2022
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- December 2022
- 119 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- September 2024
- 81 Pages
Global
From €3500EUR$4,186USD£3,088GBP
The 3D Printed Drug market is a subset of the Pharmaceutical industry that focuses on the production of drugs using 3D printing technology. This technology allows for the production of drugs with complex geometries and shapes, as well as the ability to customize drugs for individual patients. 3D Printed Drugs are typically produced using a powder-based process, where a powder is spread over a build platform and then fused together using a laser. This process allows for the production of drugs with a high degree of accuracy and precision.
The 3D Printed Drug market is expected to grow in the coming years, as the technology becomes more widely adopted. This growth is driven by the potential for improved drug efficacy, as well as the ability to customize drugs for individual patients.
Some companies in the 3D Printed Drug market include Aprecia Pharmaceuticals, 3DPharma, and 3D4MD. Show Less Read more